% | $
Quotes you view appear here for quick access.

SIGA Technologies, Inc. Message Board

toobig2failagain 44 posts  |  Last Activity: Mar 16, 2015 3:38 PM Member since: Jan 29, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • First Solar is estimated to lose $0.19 / share this quarter, while JASO just reported earnings of $0.35 / share.

    First Solar is an American company propped up by MM in the USA. Too bad FSLR does not trade at PEs of 3-5 like the Chinese solars.

    The USA will not allow FSLR to trade so low. Otherwise the Chinese would buy out FSLR, break it into 5 companies and merge them with the Chinese solars so that all the major Chinese solars would be US based and would skyrocket in PPS like FSLR with PEs in the 20s.

  • toobig2failagain by toobig2failagain Mar 16, 2015 12:08 PM Flag

    So, with FSLR earning a bit over $3.00 in 2015 and JASO winning new contract after new contract and earning $1.50 or so in 2015, a reasonable investor would think that JASO should trade at about 1/2 the price of FSLR.

    With FSLR at about $60 / share, it would be reasonable to assume JASO should trade in the range of $25-30 per share. So, is it the American market-makers (i.e. the US banks such as Citibank, JPM, etc.) manipulating the stock prices of companies such as JASO (with such stellar earnings), or is it another such manipulation of stock prices that even the SEC cannot even tell who's doing it?

    JASO is definitely being manipulated and the SEC needs to take the necessary steps to eliminate the crooked MMs or manipulators of the stock. $1.50 earnings this year!!! Should be trading a lot higher....

    Sentiment: Strong Buy

  • toobig2failagain by toobig2failagain Mar 9, 2015 12:59 PM Flag

    Oil prices climbed Monday, reversing early losses, as an industry report showed that crude stockpiles in a key storage hub rose less than expected last week.

    Light, sweet crude for April delivery rose $1.15, or 2.3%, to $50.76 a barrel on the New York Mercantile Exchange. Brent, the global benchmark, traded up 20 cents, or 0.3%, to $59.93 a barrel on ICE Futures Europe.

    Once traders realize that crude has bottomed, ORIG with almost $2 / share in earnings and a PE less than 3.5, will take off back to the $15 - $20 zone. Grab some shares at this level while you may. I got 150,000 shares this morning on the dips.

    Sentiment: Strong Buy

  • toobig2failagain by toobig2failagain Mar 6, 2015 2:23 PM Flag

    Fourth Quarter 2014 Financial Highlights
    * For the fourth quarter of 2014, the Company reported a net income of $87.5 million, or $0.66 basic and diluted earnings per share.

    * The Company reported Adjusted EBITDA of $276.7 million for the fourth quarter of 2014, as compared to $163.8 million for the fourth quarter of 2013.(1)

    Year Ended December 31, 2014 Financial Highlights
    * For the year ended December 31, 2014, the Company reported a net income of $259.8 million, or $1.96 basic and diluted earnings per share.

    Excluding various charges, the Company would have reported a net income of $314.4 million, or $2.38 per share.

    So, even with the write-offs this year and miscellaneous charges against earnings, ORIG earned $1.96 per share. At today's price that puts the current PE at about 3.5. Cannot find a better buy in the oil and gas services industry.

    And they kept the dividend. It was declared to be $0.19 / share payable later this month.

    Couldn't be a better time to buy....

    Sentiment: Strong Buy

  • toobig2failagain by toobig2failagain Mar 5, 2015 1:15 PM Flag

    Why is this POS going up? Earnings are negative and getting worse. At some point this company will have to declare bankruptcy.

    Funny how this stock is manipulated just upwards just like the very profitable stocks out there are manipulated downward when their earnings are rising. MMs are turning the stock market into a #$%$ shoot by manipulating stocks based upon illegal knowledge they gain from NSA spying technology and stealing money from individual investors.

    Sentiment: Sell

  • toobig2failagain by toobig2failagain Feb 23, 2015 10:53 AM Flag

    I believe the manipulated share price is a result of SeaDrill buying about to buy the remaining shares and the MM along with Seadrill manipulating the share price to the lowest possible price before the earnings announcement Thursday evening.

    Should fetch $4.50 - $6.50 per share.

    Sentiment: Strong Buy

  • toobig2failagain by toobig2failagain Feb 20, 2015 1:44 PM Flag

    Orig has a net tangible value of $2.973 billion and cash and equivalents of $899 million.

    And the market cap of ORIG is only $1.13 billion? That means that any company can buy ORIG at its current market price at only $231 million over available cash?

    That is ludicrous!!! If I had $231 million to trade for over $2.973 billion in assets when the company is making $2.33 est earnings this year with a 40-50 YOY growth rate, I would be a buyer of this company!!!

    So when do you think this company will be bought out at this ridiculously low valuation? With a book value of $23.51 per share, this company is a prime target for a takeover....

    Sentiment: Strong Buy

  • toobig2failagain by toobig2failagain Feb 11, 2015 3:58 PM Flag

    So, when do you think SeaDrill will buy out the remaining shares of NADL?

    It has been blatently obvious about the manipulation of the share price by the MMs of NADL (Citigroup?) over the past month and a half. SeaDrill will buy out the remaining shares at this ridiculously low price.

    NADL is super profitable and would be a major asset for SDRL if the two were to merge.

    However, to buy the remaining shares, I would suspect a leak of the immediate date will occur soon and it will be bought out in the $6.50 - $7.50 range.

    However, as for now, SDRL can buy up as many shares as the manipulated shareholders are willing to sell at these prices....

    So, does the SEC ever prosecute companies anymore for stock price manipulation???

    Sentiment: Strong Buy

  • toobig2failagain by toobig2failagain Feb 10, 2015 8:32 AM Flag

    Seadrill is the prime leader in offshore drilling. Petrobas' success is directly tied to SeaDrill.

    With earnings like this and moderating oil prices, SDRL should recover back to the $15 - $20 range soon.

    Buying opportunity of a lifetime!!

    Sentiment: Strong Buy

  • I recently upgraded to the 100 mbps speed with Time Warner Cable. However, I only get about 3 mbps download speeds despite speed tests that range between 75 and 100 mbps. I noticed that my firewall is constantly being modified by companies such as F5 Networrks, Checkpoint, and SonicWALL to allow for VPN use of my computer through the firewall. And my computer runs super slow during business days with hidden processes chewing up 97 percent of my bandwidth.

    I noticed that F5 Networks -- f5vpn -- is the primary culprit stealing my bandwidth. So, is this company's whole model based upon attaching to various residential cable modems throughout the United States and / or world and stealing their bandwidth without informing the paying subscribers (residential customers of cable internet) for their internet theft and allowing massive security breaches into their files and data content on their computer systems? Really? Is that even legal?

    This company needs to be put out of business by the SEC and investigated by the FBI. It needs to be fined for stealing content and data off of the IPs it sets up its distributed network via hidden VPN software on the servers it sets up on residential PCs.

    Can someone tell me who at F5 in the Legal Department I can contact to file my lawsuit against them and receive just compensation for the years of stolen bandwidth and theft of files (and my time trying to counter the hidden processes loading F5 Network VPN software onto my operating system without my permission!!!!)?

    Sentiment: Strong Sell

  • toobig2failagain toobig2failagain Jan 17, 2015 4:10 AM Flag

    May 14, 2011 12:30 am -- Corvallis Gazette-Times

    Deal for smallpox drug starts at $433 million but could rise to $2.8 billion. ....

    The small biotech company, which has labs in Corvallis and headquarters in New York City, announced Friday that it has signed a contract with the Biomedical Advanced Research and Development Authority to deliver 2 million courses of its novel anti-smallpox drug for the nation's biodefense stockpiles.

    The initial value of the BARDA deal is $433 million over five years, but the agreement includes options for as many as 12 million additional courses of the drug, known as ST-246. If all the options are exercised, the ultimate value of the contract would be $2.8 billion. ...


    Contract dose revenue was contracted to BARDA at $216.50 / dose, based upon 2 million doses at $433 million over 5 years, according to the article above. Another article, on 11/6/2013, states that Siga was given the contract for 1.7 million doses of the drug, called ST-246, for about $255 per dose. SIGA was announcing "deferred revenue", that equated to $119.24 / dose. This later article was written after the award of the contract, so is more reliable. So, is SIGA recording only half of the actual revenue by only announcing "deferred revenue" of $119.24 / dose? What happened to the $255 / dose? Is the cash for the revenue for the delivery of ST-246 to BARDA from SIGA only reflecting SIGA's portion of a 50-50 split between SIGA and Pharmathene? Seems that SIGA's accounting in their reported statements is very questionable with the release of information from articles as to the nature and amount of the contract at the time of the award....

    Anybody know why the BARDA contract amount given to SIGA is only 1/2 of the contracted amount per dose?

    Sentiment: Strong Buy

  • toobig2failagain toobig2failagain Jan 17, 2015 3:08 AM Flag

    SIGA cash on 12/31/2012 was about $32.0 million, with $34.5 million in net receivables and $20.5 million in inventory.

    Interestingly enough, the 12/31/2013 income statement of SIGA only shows $5.5 million in revenue, a net loss of ($17.2 million), but no sign of the deferred revenue in the annual income stmt. However, the Balance Sheet, ending 12/31/2013, shows an increase of $52.5 million in "Deferred Long Term Asset Charges" from the previous year, and an increase of $105 million over the previous year in "Deferred Long Term Liability Charges". Cash, as of 12/31/2013, was $91.3 million, an increase of $59.3 million over the previous year. Considering SIGA received $109.7 million in deferred revenue from BARDA in 2013, we can assume SIGA hid $33.2 million in its balance sheet ($109.7 - 59.3 million cash difference - $17.2 million income loss). Since the "Deferred Long Term Asset Charges" increase by about the same amount as cash increased, we can assumed the "deferred revenue" went directly into "Deferred Long Term Assets". It appears that the missing $33.2 million in "actual" deferred revenue was incorrectly classified in the "Deferred Long Term Liability Charges". This amount, in DLTLC should have been $76.2 million, not the $109.7 million actually reported, and the "Deferred Long Term Asset Charges" should have been $98.7 million instead of the reported $65.5 million. In turn, "Cash and Equivalents" on 12/31/2013 should have been reported as $124.5 million, instead of the reported $91.3 million. Incorrect accounting not caught by the auditors....

    In 2014, SIGA accountants made even greater mistakes in accounting for the missing revenue and cash.... Wonder if the BK court can hire a few auditors from the IRS to realize that SIGA is a non-bankrupt company, sound, and with much more cash than reported previously misreported.... And wonder if this money wasn't stolen or loaned to the executive team through FRAUD...

    Sentiment: Strong Buy

  • On March 10, 2014, SIGA reported the following:
    In 2013, SIGA delivered approximately 920,000 courses of Arestvyr to the U.S. Strategic National Stockpile, of which approximately 195,000 courses were delivered at no cost to the Biomedical Advanced Research and Development Authority (BARDA) in accordance with the BARDA contract. For deliveries of product, and other related activities, SIGA received $109.7 million from BARDA in 2013. In accordance with generally accepted accounting principles, substantially all of the cash received from BARDA has been classified as deferred revenue in SIGA's financial statements. In February 2014, SIGA delivered approximately 256,000 courses of Arestvyr to the U.S. Strategic National Stockpile, of which approximately 192,000 courses will be invoiced and the remainder will be at no cost to BARDA.

    Therefore, deferred revenue thru 2/28/2014 = $109.7 million (920,000 * $119.24 / course) + $22.9 million (192,000 * $119.24) = $132.6 million. Now, let's conservatively assume that SIGA has delivered just 75,000 courses per month since 2/28/2014, based upon Feb 2014 data and on the fact that the original delivery started in about 8/2013 and averaged about 184,000 courses per month. Thru 1/15/2015, SIGA should have delivered and billed for another 787,500 courses, or 10.5 months * 75,000 courses / month, for an additional $93.9 million. Now, I am being conservative. The original contract was for 2 million doses, with the option to extend another 12 million doses. The extension part of the contract (the 12 million doses) was removed from the contract when Chimerix complained to BARDA. So, as of 1/15/2015, SIGA should have delivered approximately 1.9 million doses to BARDA as of 1/15/2015 (920,000 thru 12/31/2013 + 192,000 thru 2/2014 + 787,500 thru 1/15/2015). Deferred revenue, as of 1/15/2015, should be about $109.7 million + $22.9 million + ~$93.9 million = $226.5 million. So, where did the $226.5 million of deferred revenue go?

    Sentiment: Strong Buy

  • Depending upon how long this meeting goes, we may hear today whether PIP gets all of SIGA's assets. Market value of SIGA is only 1/3 of what they owe, but SIGA has nearly $290 million in cash and deferred revenue hidden in its balance sheet.

    SIGA is not bankrupt and DOES have the cash (although hidden with various accounting tricks). Bankruptcy judge and the NY court accountants should see through the sham and pass the assets to PIP and the other creditors....

    Meeting began at 11:00 a.m. EST and will last probably most of today.

    Sentiment: Strong Buy

  • toobig2failagain by toobig2failagain Jan 2, 2015 3:59 PM Flag

    Should hear about this soon....

    Sentiment: Strong Buy

  • toobig2failagain by toobig2failagain Jan 2, 2015 3:57 PM Flag

    Siga had asked for a 30 day extension on 12/16/2014 and obviously had been granted the extension for the meeting of debtors.

    There is a court hearing on 1/13/2015 at 11:00 AM at Courtroom 701 (SHL) .

    Parsons ruling coming by 1/16/2015 because debtors will be coming to collect from Siga on that day.

    About time Parsons rules....

    Sentiment: Strong Buy

  • toobig2failagain by toobig2failagain Dec 31, 2014 3:58 PM Flag

    Why would not SIGA or any other company, for that matter, buy out PIP for $250 - $300 million right now, since the judgment is imminent and there is about a 95 percent probability the judgement will be within range of PIP's and SIGA's estimate of Parson's damages?

    A $4.00 bid for the company by SIGA would enable SIGA to take back (with no losses) all of the damages paid to PIP without paying a cent, since it would own the company outright, and also get all of the additional drugs of PIP's in the pipeline without any additional cost. And why wouldn't any other company make the bid for the company right now since PIP is priced just for its existing drugs?

    Seems like it would be a sure double to triple for any company buying PIP even at $4.00 - $6.00 per share.

    I do not understand why the market does not price in an almost sure thing such as the damages award that must be announced by March for SIGA to emerge from bankruptcy like it has stated in its filings.

    Man, there are a lot of stupid investors, investment banks, and competing companies out there.

    Sentiment: Strong Buy

  • toobig2failagain by toobig2failagain Nov 20, 2014 9:19 AM Flag

    Amazing beat!! JKS should make over $3.50 / share this year (2014) and $4 - 6 / share next year.

    And trading at a forward PE of 6.72 on 2014 earnings and 4.70 on 2015 earnings est.

    Best buy in the solar field, IMHO.

    Sentiment: Strong Buy

  • toobig2failagain by toobig2failagain Nov 20, 2014 8:35 AM Flag

    Awesome earnings. Earnings blow-out!!! $1.32 / share this quarter versus $0.72 last year.

    Analyst consensus for this quarter was only $0.71 / share. Beat this estimate by $0.61 / share -- or 86 percent.

    Revenue came in slightly lower than the estimates, but who cares if they are that profitable at these levels. PE now at ridiculously low levels. Should be priced in the $40 with these earnings!

    Sentiment: Strong Buy

  • It is quite evident that Pharmathene's stock price is being manipulated by the MMs on very little volume.

    Oddly enough, SIGA appears to do all its banking in San Antonio, TX, when its case is being litigated in Delaware and its bankruptcy is being handled by the Bankruptcy Court in New York state. Any significance to San Antonio, or are all federal bank CBO services handled by the US military in San Antonio?

    Bankrupcy case shows no significant debts owed by SIGA, although SIGA has disclosed it has $386.7 million in "Liabilities Subject to Compromise". Interesting.... With $103 million in cash, $18 million in inventory, and $175.1 million in additional paid-in capital (hidden cash from sales?), SIGA looks quite profitable and capable of paying off its debts in BK.

    We shall see. All BK proceedings and arguments have been completed. Now just awaiting judgment from the Delaware court. Nothing on court schedule but the meeting with the creditors on 12-18-2014. With the BK proceeding finalized in mid-December, and all that hidden money in SIGAs bank (San Antonio, TX?), seems as though someone is attempting to buy this company out very soon.... Doesn't the incumbent mayor of NY city and several major New York City businessmen also bank through Citibank in San Antonio?

    Sentiment: Strong Buy

2.050.0000(0.00%)Mar 19 4:00 PMEDT